Vericel

$19.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-1.72%) As of 11:19 AM EDT today

Why Robinhood?

You can buy or sell Vericel and other stocks, options, and ETFs commission-free!

About VCEL

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. Read More The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA. The listed name for VCEL is Vericel Corporation Common Stock.

Employees
241
Headquarters
Cambridge, Massachusetts
Founded
1989
Market Cap
902.52M
Price-Earnings Ratio
Dividend Yield
Average Volume
448.97K
High Today
$20.30
Low Today
$19.72
Open Price
$19.84
Volume
100.40K
52 Week High
$22.26
52 Week Low
$6.78

Collections

VCEL Earnings

-$0.21
-$0.07
$0.06
$0.20
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Nov 5, Pre-Market

You May Also Like